Lin G - Search Results

1

The pentapeptide PLNPK inhibits systemic lupus erythematosus-associated renal damage.

Lv JQ, Zhang W, Wang S, Zhao L, Ma R, Hu JW, Wang LJ, Meng J, Zhou CL, Lin G, Lu R, Yao Z. Lv JQ, et al. Among authors: lin g. Inflamm Res. 2010 Dec;59(12):1081-9. doi: 10.1007/s00011-010-0228-y. Epub 2010 Jul 1. Inflamm Res. 2010. PMID: 20593216

2

The synthesis, distribution, and anti-hepatic cancer activity of YSL.

Ding W, Zhang J, Yao Z, Lu R, Wu D, Li G, Shen Z, Sun Y, Lin G, Wang C, Zhao M, Peng S. Ding W, et al. Among authors: lin g. Bioorg Med Chem. 2004 Sep 15;12(18):4989-94. doi: 10.1016/j.bmc.2004.06.030. Bioorg Med Chem. 2004. PMID: 15336278

3

Preliminary investigation of the inhibitory effects of the tyroservaltide (YSV) tripeptide on human hepatocarcinoma BEL-7402.

Jia J, Lu R, Qiu S, Li H, Che X, Zhao P, Jin M, Yang H, Lin G, Yao Z. Jia J, et al. Among authors: lin g. Cancer Biol Ther. 2005 Sep;4(9):993-7. doi: 10.4161/cbt.4.9.1968. Epub 2005 Sep 23. Cancer Biol Ther. 2005. PMID: 16082190 Free article.

4

Effects of a novel tripeptide, tyroserleutide (YSL), on cell cycle progression of human hepatocellular carcinoma.

Wang C, Wang S, Lu R, Zhao L, Zhu ZF, Xu Q, Lv JQ, Wang LL, Fu Z, Lin G, Yao Z. Wang C, et al. Among authors: lin g. Anticancer Drugs. 2009 Aug;20(7):534-42. doi: 10.1097/CAD.0b013e32832ced93. Anticancer Drugs. 2009. PMID: 19491661

5

Effects of tyroservatide on histone acetylation in lung carcinoma cells.

Xu Q, Lu R, Zhu ZF, Lv JQ, Wang LJ, Zhang W, Hu JW, Meng J, Lin G, Yao Z. Xu Q, et al. Among authors: lin g. Int J Cancer. 2011 Jan 15;128(2):460-72. doi: 10.1002/ijc.25346. Epub 2010 Mar 22. Int J Cancer. 2011. PMID: 20309941

6

The new immunosuppressant PLNPK prolongs allograft survival in mice.

Wang L, Wang S, Lu R, Lv J, Zhou C, Fu Z, Xu Q, Che X, Jia J, Zhao H, Li X, Lin G, Yao Z. Wang L, et al. Among authors: lin g. Transpl Immunol. 2010 Oct;24(1):64-8. doi: 10.1016/j.trim.2010.09.001. Epub 2010 Sep 17. Transpl Immunol. 2010. PMID: 20850529

7

The latest developments in synthetic peptides with immunoregulatory activities.

Zhou CL, Lu R, Lin G, Yao Z. Zhou CL, et al. Among authors: lin g. Peptides. 2011 Feb;32(2):408-14. doi: 10.1016/j.peptides.2010.10.019. Epub 2010 Oct 25. Peptides. 2011. PMID: 20979984 Review.

8

Expression, purification, and activity assay of peptide deformylase from Escherichia coli and Staphylococcus aureus.

Che X, Hu J, Wang L, Zhu Z, Xu Q, Lv J, Fu Z, Sun Y, Sun J, Lin G, Lu R, Yao Z. Che X, et al. Among authors: lin g. Mol Cell Biochem. 2011 Nov;357(1-2):47-54. doi: 10.1007/s11010-011-0874-6. Epub 2011 May 21. Mol Cell Biochem. 2011. PMID: 21603885

9

Tyroservatide therapy for tumor invasion and metastasis of human ovarian carcinoma and colon carcinoma.

Wang L, Che X, Li X, Lv J, Zhou C, Wang S, Zhu Z, Wang L, Lin G, Lu R, Yao Z. Wang L, et al. Among authors: lin g. Anticancer Drugs. 2012 Nov;23(10):1067-77. doi: 10.1097/CAD.0b013e328357bd31. Anticancer Drugs. 2012. PMID: 22922208

10

Effects of Tyroserleutide on phosphatidylinositol 3'-kinase/AKT pathway in human hepatocellular carcinoma cell.

Fu Z, Ren L, Wei H, Lv J, Che X, Zhu Z, Jia J, Wang L, Lin G, Lu R, Yao Z. Fu Z, et al. Among authors: lin g. J Drug Target. 2014 Feb;22(2):146-55. doi: 10.3109/1061186X.2013.844820. Epub 2013 Oct 23. J Drug Target. 2014. PMID: 24147456

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,423 results

Search Page

Filters